| Entry |
|
|---|
| Name |
Cinolazepam (INN);
Gerodorm (TN) |
|---|
| Formula |
C18H13ClFN3O2
|
|---|
| Exact mass |
357.068
|
|---|
| Mol weight |
357.7661
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01835 Benzodiazepine sedative-hypnotics
|
|---|
| Remark |
|
|---|
| Efficacy |
Sedative-hypnotic |
|---|
| Comment |
Benzodiazepine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CD Benzodiazepine derivatives
N05CD13 Cinolazepam
D07328 Cinolazepam (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01835 Benzodiazepine sedative-hypnotics
D07328 Cinolazepam
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D07328 Cinolazepam (INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 25
1 C2y C 26.9500 -20.2300
2 C8y C 26.1100 -19.1100
3 C8y C 26.4600 -17.7100
4 N1y N 27.7200 -17.1500
5 N2x N 28.4200 -20.2300
6 C5x C 28.9800 -17.7800
7 C1y C 29.2600 -19.1800
8 C8x C 25.4800 -16.7300
9 C8x C 24.1500 -17.1500
10 C8y C 23.8000 -18.4800
11 C8x C 24.7800 -19.4600
12 O5x O 30.0300 -16.8700
13 X Cl 22.4000 -18.9000
14 C8y C 26.3200 -21.4900
15 C8x C 24.9200 -21.4900
16 C8x C 24.2200 -22.6800
17 C8x C 24.9200 -23.8700
18 C8x C 26.3200 -23.8700
19 C8y C 27.0200 -22.6800
20 X F 28.4900 -22.6800
21 C1b C 27.7200 -15.7500
22 C1b C 28.9800 -15.1200
23 C3b C 28.9800 -13.6500
24 O1a O 30.6203 -19.5110
25 N3a N 28.9625 -12.2527
BOND 27
1 3 4 1
2 1 5 2
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 6 12 2
14 10 13 1
15 1 14 1
16 14 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 18 19 1
21 14 19 2
22 19 20 1
23 4 21 1
24 21 22 1
25 22 23 1
26 7 24 1
27 23 25 3
|
|---|
